跳至主要内容
临床试验/IRCT20141227020441N7
IRCT20141227020441N7招募中3 期

Evaluating the efficacy of ginseng supplement in the prevention of cardiac toxicity induced by anthracyclines in breast cancer patients

Shiraz University of Medical Sciences0 个研究点目标入组 62 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
62

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • The ages of 18 to 65 years
  • Patients with non-metastatic breast cancer
  • Receiving the first course of anthracycline based chemotherapy

排除标准

  • History of therapy with anthracyclines
  • Metastatic or recurrent breast cancer
  • History of solid tumors and receiving systemic therapy
  • LVEF below 50%
  • History of chronic diseases ( DM, cardiac disease. renal failure)
  • Pregnancy and lactation

研究者

相似试验